(NASDAQ: CARL) Carlsmed's forecast annual revenue growth rate of 46.04% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 9.02%, and it is also forecast to beat the US market's average forecast revenue growth rate of 15.36%.
Carlsmed's revenue in 2026 is $50,511,000.On average, 7 Wall Street analysts forecast CARL's revenue for 2026 to be $1,985,197,922, with the lowest CARL revenue forecast at $1,870,490,944, and the highest CARL revenue forecast at $2,083,678,580. On average, 7 Wall Street analysts forecast CARL's revenue for 2027 to be $2,793,760,484, with the lowest CARL revenue forecast at $2,546,382,630, and the highest CARL revenue forecast at $2,938,915,200.
In 2028, CARL is forecast to generate $3,867,317,283 in revenue, with the lowest revenue forecast at $3,497,881,153 and the highest revenue forecast at $4,123,409,766.